Evidence-Based Pharmacotherapies and Oral Doses as Shown in Large Clinical Trials

 As prepared for workshop series. 

 

 

Drug Class Specific Agent Start Dose Target Dose
ARNI Sacubitril-valsartan 50-100 mg BID (dose rounded) 200 mg BID (dose rounded)
ACE inhibitor Enalapril 1.25-2.5 mg BID 10 mg BID / 20 mg BID in NYHA IV
  Lisinopril 2.5-5 mg daily 20-35 mg daily
  Perindopril 2-4 mg daily 4-8 mg daily
  Ramipril 1.25-2.5 mg BID 5 mg BID
  Trandalopril 1-2 mg daily 4 mg daily
ARB Candesartan 4-8 mg daily 32 mg daily
  Valsartan 40 mg BID 160 mg BID
Beta-blocker Carvedilol 3.125 mg BID 25 mg BID / 50 mg BID (>85 kg)
  Bisoprolol 1.25 mg daily 10 mg daily
  Metoprolol (CR/XL) 12.5-25 mg daily 200 mg daily
MRA Spironolactone 12.5 mg daily 25-50 mg daily
  Eplerenone 25 mg daily 50 mg daily
SGLT2 inhibitor Dapagliflozin 10 mg daily 10 mg daily
  Empagliflozin 10 mg daily 10-25 mg daily
  Canagliflozin 100 mg daily 100-300 mg daily
Sinus node inhibitor Ivabradine 2.5-5 mg BID 7.5 mg BID
sGC stimulator Vericiguat 2.5 mg daily 10 mg daily
Vasodilator Hydralazine/Isosorbide Dinitrate 10-37.5 mg TID / 10-20 mg TID 75-100 mg TID or QID / 40 mg TID
Cardiac glycosides Digoxin 0.0625-0.125 mg daily N/A: monitor for toxicity